EOLS vs LYB · rev $157.2M vs P/E 21, rev $16.37B
Evolus Inc (EOLS) versus LyondellBasell Industries NV (LYB) — a side-by-side from cached financials, not a winner call.
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Latest reported EOLS revenue for 2026-06-30 was $157.2M. Net income was -$18.7M. EOLS currently screens at market cap $597.0M.
Latest reported LYB revenue for 2026-06-30 was $16.37B. Net income was $684.0M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
EOLS currently screens at market cap $597.0M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Not investment advice. Open the EOLS and LYB stock pages for the full models.
Not investment advice.